Chinese researchers announced that they are 99% confident that the vaccine they are developing will be effective in fighting the emerging coronavirus.

According to Arabia Net, the Chinese newspaper Sinovac, a Chinese biotechnology research company, has entered into the second stage of experiments for the vaccine it is working to develop in order to develop. Anti-Corona virus, with more than a thousand volunteers participating in this stage, amid great optimism among researchers that they will soon be able to produce the appropriate vaccine that will eliminate the virus.

The company also said that it had started to conduct preliminary talks in order to enter the third stage of the experiments, which are experiments that will be conducted inside Britain, and this stage will be the last in the field Research is ongoing, according to the Sun newspaper.

Liu Beishan, a researcher with the Chinese company, said in response to a question whether the tests conducted so far were successful or not: yes yes .. it is definitely successful .. I am 99% sure of it.

<> dir = "rtl" style = "text-align: justify;"> The company Sinovac published the results of its medical research in a scientific journal late last month and revealed the vaccine that it called Corona Vac, and said at the time that it succeeded in protecting Monkeys infection from the emerging corona virus.

The company said at the time that it hoped to conduct clinical trials of this vaccine at its three levels outside China, due to the decline in infections inside China to the point that making these experiments difficult to make .

Helen Young, executive director of investor relations at the company, said: We are talking to many European countries and I think we have had good talks with Britain, but she added, saying: What We are still in the preliminary stage of the talks.

Sinovac confirmed that although experiments are still under way on this vaccine, it is still proceeding with its production processes in parallel with the experiments, where it hopes to produce huge quantities once The experiments are successful in all its stages and upon obtaining the necessary legal and regulatory approvals for its use.

The company says that the commercial plant for this vaccine has already started construction in the Chinese capital, Beijing, and will be able to produce more than 100 million doses of vaccine once clinical trials are completed and clearances are obtained. Necessary to use it.

"We do not recommend that all residents take the vaccine," says Young. We discussed this with many countries and we recommend them to this, as we are targeting in the beginning ...